{"id":"3a9dc1d7-e6bc-5a43-a389-e3065bcd4757","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-only-sensitive-patients-release","predicate":"increases","statement":"After nasal instillation of 12 milligrams of acetylsalicylic acid, significant levels of peptide leukotrienes were detected in sensitive asthmatic patients at 60 minutes in association with a significant increase in symptoms, with no increase in either insensitive patients or healthy subjects, while inhibition of prostaglandin E2 and F2-alpha release was detected in all three groups; aspirin also inhibited prostaglandin D2 release in insensitive asthmatic patients but not in sensitive patients or healthy subjects.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"83ab57d5-9e5f-5b8d-99e6-c8cb81fcf05b","mechanism_event_label":"The drug blocks prostaglandins in everyone, but only in the sensitive patients does a flood of leukotrienes follow.","subject":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"object":{"id":"a1b4b3a8-008f-5da7-8ac6-4767d010817d","slug":"peptide-leukotrienes","display_name":"Peptide (cysteinyl) leukotrienes","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"83ab57d5-9e5f-5b8d-99e6-c8cb81fcf05b","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-only-sensitive-patients-release-event","event_type":"observed_intervention","label":"The drug blocks prostaglandins in everyone, but only in the sensitive patients does a flood of leukotrienes follow.","description":"After nasal instillation of 12 milligrams of acetylsalicylic acid, significant levels of peptide leukotrienes were detected in sensitive asthmatic patients at 60 minutes in association with a significant increase in symptoms, with no increase in either insensitive patients or healthy subjects, while inhibition of prostaglandin E2 and F2-alpha release was detected in all three groups; aspirin also inhibited prostaglandin D2 release in insensitive asthmatic patients but not in sensitive patients or healthy subjects.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"7f2ceef8-279f-5e28-9341-ba8edeb7cc38","slug":"aspirin-exacerbated-respiratory-disease","display_name":"Aspirin-sensitive asthma and rhinitis","entity_type_key":"cellular_process"},"role":"defining_condition","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"5733d7d1-6259-588f-a4a9-4d0dc0133735","slug":"prostaglandin-e2","display_name":"Prostaglandin E2","entity_type_key":"small_molecule"},"role":"suppressed_in_all","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"51dae53e-ef81-5060-98e8-b1a519819cb6","slug":"prostaglandin-d2","display_name":"Prostaglandin D2","entity_type_key":"small_molecule"},"role":"differential_marker","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"a1b4b3a8-008f-5da7-8ac6-4767d010817d","slug":"peptide-leukotrienes","display_name":"Peptide (cysteinyl) leukotrienes","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/1309968.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a81a9ed941df59e6b8aa8c7c730d9a14766e2b8bd358b712ee464ae96c67e4e2\", \"start_char\": 0, \"end_char\": 1685, \"text_sha256\": \"a81a9ed941df59e6b8aa8c7c730d9a14766e2b8bd358b712ee464ae96c67e4e2\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Double-blind nasal lavage challenge in ten aspirin-sensitive asthmatics, ten insensitive asthmatics and seven healthy subjects","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"12 milligrams of acetylsalicylic acid instilled nasally against saline","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Three groups including two control groups, with mediators measured directly in the target tissue. Radioimmunoassay of nasal lavage fluid, and a small number per group.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The drug blocks prostaglandins in everyone, but only in the sensitive patients does a flood of leukotrienes follow.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p1309968] Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. (1992). https://pubmed.ncbi.nlm.nih.gov/1309968/ DOI: 10.1164/ajrccm/145.1.65","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Nasal mucosa","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"75b5f913-4121-590d-8f1b-d78825764b24","evidence_kind":"source_excerpt","locator":"Lines 572-583","start_line":572,"end_line":583,"excerpt":"### asa-only-sensitive-patients-release\nAfter nasal instillation of 12 milligrams of acetylsalicylic acid, significant levels of peptide leukotrienes were detected in sensitive asthmatic patients at 60 minutes in association with a significant increase in symptoms, with no increase in either insensitive patients or healthy subjects, while inhibition of prostaglandin E2 and F2-alpha release was detected in all three groups; aspirin also inhibited prostaglandin D2 release in insensitive asthmatic patients but not in sensitive patients or healthy subjects.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: The drug blocks prostaglandins in everyone, but only in the sensitive patients does a flood of leukotrienes follow.\norganism: Human\ntissue_or_cell_type: Nasal mucosa\nexperimental_model: Double-blind nasal lavage challenge in ten aspirin-sensitive asthmatics, ten insensitive asthmatics and seven healthy subjects\nlimitations: Three groups including two control groups, with mediators measured directly in the target tissue. Radioimmunoassay of nasal lavage fluid, and a small number per group.\nexposure: 12 milligrams of acetylsalicylic acid instilled nasally against saline\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/1309968.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"a81a9ed941df59e6b8aa8c7c730d9a14766e2b8bd358b712ee464ae96c67e4e2\", \"start_char\": 0, \"end_char\": 1685, \"text_sha256\": \"a81a9ed941df59e6b8aa8c7c730d9a14766e2b8bd358b712ee464ae96c67e4e2\"}\n[asa-p1309968] Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. (1992). https://pubmed.ncbi.nlm.nih.gov/1309968/ DOI: 10.1164/ajrccm/145.1.65","model_system":"Double-blind nasal lavage challenge in ten aspirin-sensitive asthmatics, ten insensitive asthmatics and seven healthy subjects","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p1309968] Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. (1992). https://pubmed.ncbi.nlm.nih.gov/1309968/ DOI: 10.1164/ajrccm/145.1.65","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}